Localized Lymphadenitis, Lymphadenopathy, and Lymphangitis

Myers, Angela

doi:10.1016/b978-0-323-40181-4.00020-7

Cited by 2 publications

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most commonly associated bacteria are Streptococcus pyogenes and Staphylococcus aureus. Meanwhile, lymphangitis is a more severe inflammation of the lymphatic vasculature system in the subcutaneous layer involving bacteria (acute), or in more chronic conditions it can be caused by fungi, mycobacterium, or parasites [68][69][70]. In tropical regions, some parasites such as Wuchereria bancrofti, Brugia timori, and Brugia malayi can invade the lymphatic system.…”

Section: Lymphatic Infectionsmentioning

confidence: 99%

Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes

et al. 2023

View full text Add to dashboard Cite

Globally, the increase of pathogenic bacteria with antibiotic-resistant characteristics has become a critical challenge in medical treatment. The misuse of conventional antibiotics to treat an infectious disease often results in increased resistance and a scarcity of effective antimicrobials to be used in the future against the organisms. Here, we discuss the rise of antimicrobial resistance (AMR) and the need to combat it through the discovery of new synthetic or naturally occurring antibacterial compounds, as well as insights into the application of various drug delivery approaches delivered via various routes compared to conventional delivery systems. AMR-related infectious diseases are also discussed, as is the efficiency of various delivery systems. Future considerations in developing highly effective antimicrobial delivery devices to address antibiotic resistance are also presented here, especially on the smart delivery system of antibiotics.

show abstract

Section: Lymphatic Infectionsmentioning

confidence: 99%